Interpharm(OTC) IPAH

Market Cap$700.00

Since IPO (1993)-100%

5 Year-98%

1 Year+900%

1 Month+900%

$0.00

+0.00%

+0.00Today

Interpharm last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-06-05

Interpharm stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+900%	USD 0.00	2026-05-04
1 month	+900%	USD 0.00	2026-05-04
3 month	+900%	USD 0.00	2025-12-09
Year to date	+900%	USD 0.00	2025-12-09
1 year	+900%	USD 0.00	2025-03-19
3 year	+900%	USD 0.00	2023-05-09
5 year	-98%	USD 0.00	2021-05-24
Since inception	-100%	USD 362.50	1993-02-12

Interpharm Financials at a Glance

Market Cap

$700.00

Revenue (TTM)

$69.21M

Net Income (TTM)

-$29.36M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-575.58 (Low)

Dividend

$0.00

Beta (Volatility)

-575.58 (Low)

Price

$0.00

Volume

500

Open

$0.00

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

-575.58 (Low)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

IPAH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Interpharm

Interpharm Holdings, Inc. engages in the development, manufacture and distribution of pharmaceutical products. The company was founded on July 17, 1992 and is headquartered in Hauppauge, NY.

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Hauppauge, NY 11788, US

IPAH Financials

Key Financial Metrics (TTM)

Gross Margin

28.66%

Operating Margin

-14.21%

Net Income Margin

-18.60%

Return on Equity

-82.09%

Return on Capital

-28.28%

Return on Assets

-18.90%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-0.88%

Stock Overview

Market Cap

$700.00

Shares Outstanding

66.74M

Volume

500

Avg. Volume

7.937

Financials (TTM)

Gross Profit

$12.00M

Operating Income

-$19.72M

EBITDA

-$16.36M

Operating Cash Flow

-$21.75M

Capital Expenditure

-$7.86M

Free Cash Flow

-$29.61M

Cash & ST Invst.

$41.00K

Total Debt

$38.47M

Interpharm Performance Analysis

Interpharm sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2007-03-31	13.9%
Q4	2007-06-30	-22.8%
Q1	2007-09-30	15.2%
Q2	2007-12-31	-8.5%

Interpharm sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2007-03-31	42.9%
Q4	2007-06-30	-283.2%
Q1	2007-09-30	34.8%
Q2	2007-12-31	-110.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2007YOY CHG

Revenue

$16.21M

-7.2%

Gross Profit

$2.27M

-43.8%

Gross Margin

13.99%

N/A

Market Cap

$700.00

N/A

Market Cap/Employee

$1.04

N/A

Employees

670

N/A

Net Income

-$10.90M

-164.2%

EBITDA

-$2.97M

+18.8%

Quarterly Fundamentals

Name

Q2 2007YOY CHG

Total Cash

$41.00K

-99.4%

Total Debt

$38.47M

+146.5%

Accounts Receivable

$13.72M

+20.9%

Inventory

$12.26M

+25.0%

Long Term Debt

$7.79M

-43.5%

Short Term Debt

$30.68M

+1597.0%

Return on Assets

-18.90%

N/A

Return on Invested Capital

-24.53%

N/A

Free Cash Flow

-$6.91M

-53.1%

Operating Cash Flow

-$6.35M

-96.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PXYNPraxsyn Corporation

PXYNPraxsyn Corporation$0.00+0.00%

MHTXManhattan Scientifics, Inc.

MHTXManhattan Scientifics, Inc.$0.00+0.00%

DNAGDNAPrint Genomics, Inc.

DNAGDNAPrint Genomics, Inc.$0.00+0.00%

SPPHSpencer Pharmaceutical Inc.

SPPHSpencer Pharmaceutical Inc.$0.00+0.00%

CBGLCannabis Global Inc.

CBGLCannabis Global Inc.$0.00+0.00%

USRMU.S. Stem Cell, Inc.

USRMU.S. Stem Cell, Inc.$0.00+0.00%

INLBItem 9 Labs Corp.

INLBItem 9 Labs Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PLTRPalantir Technologies

PLTRPalantir Technologies$162.66+0.29%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$125.33+0.09%

NVDANvidia

NVDANvidia$211.94+0.03%

INTCIntel

INTCIntel$100.86+0.11%

AMIXAutonomix Medical

AMIXAutonomix Medical$19.50+4.34%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$8.07+0.03%

NOKNokia

NOKNokia$9.92+0.06%

Questions About IPAH

What is the current price of Interpharm?

Interpharm is trading at $0.00 per share.

What is the 52-week range for Interpharm?

Over the past 52 weeks, Interpharm has traded between $0.00 and $0.00.

How much debt does Interpharm have?

Interpharm total debt is unavailable.

How much cash does Interpharm have on hand?

Interpharm does not have cash on hand data available.

What is Interpharm’s dividend yield?

Interpharm does not currently have a dividend yield.

Interpharm(OTC) IPAH

Interpharm Financials at a Glance

IPAH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Interpharm

IPAH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Interpharm Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IPAH

What is the current price of Interpharm?

What is the 52-week range for Interpharm?

How much debt does Interpharm have?

How much cash does Interpharm have on hand?

What is Interpharm’s dividend yield?

Premium Investing Services